{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:32:48Z","timestamp":1793914368290,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12876-018-0843-6","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T07:45:46Z","timestamp":1530863146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0745-7383","authenticated-orcid":false,"given":"Bashu Dev","family":"Pardhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreena","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjeela","family":"Bhetwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puspa Raj","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari Om","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujan Babu","family":"Marahatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"issue":"3","key":"843_CR1","first-page":"1198","volume":"7","author":"A Santoshini","year":"2016","unstructured":"Santoshini A, Swathi P, Babu SR, Nair R. Estimation of lipid profile in various grades of non alcoholic fatty liver disease diagnosed on ultrasonography. Int J Pharm Bio Sci. 2016;7(3):1198\u2013203.","journal-title":"Int J Pharm Bio Sci"},{"issue":"2","key":"843_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","volume":"68","author":"A Lonardo","year":"2018","unstructured":"Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol. 2018;68(2):335\u201352.","journal-title":"J Hepatol"},{"issue":"6","key":"843_CR3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005\u201323.","journal-title":"Hepatology"},{"key":"843_CR4","doi-asserted-by":"publisher","unstructured":"Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res. 2012;2012(145754):12. \n                    https:\/\/doi.org\/10.1155\/2012\/145754\n                    \n                  .","DOI":"10.1155\/2012\/145754"},{"issue":"6","key":"843_CR5","doi-asserted-by":"publisher","first-page":"e010342","DOI":"10.1136\/bmjopen-2015-010342","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang S, Zhang C, Zhang G, Yuan Z, Liu Y, Ding L, et al. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study. BMJ Open. 2016;6(6):e010342.","journal-title":"BMJ Open"},{"issue":"12","key":"843_CR6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","volume":"47","author":"A Lonardo","year":"2015","unstructured":"Lonardo A, Bellentani S, Argo CK, Ballestri S, Byrne CD, Caldwell SH, et al. Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups. Dig Liver Dis. 2015;47(12):997\u20131006.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"843_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/met.2011.0016","volume":"9","author":"R Villegas","year":"2011","unstructured":"Villegas R, Xiang Y-B, Elasy T, Cai Q, Xu W, Li H, et al. Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese men. Metab Syndr Relat Disord. 2011;9(4):305\u201311.","journal-title":"Metab Syndr Relat Disord"},{"issue":"5","key":"843_CR8","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2337\/diacare.27.5.1182","volume":"27","author":"C-E Tan","year":"2004","unstructured":"Tan C-E, Ma S, Wai D, Chew S-K, Tai E-S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27(5):1182\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"843_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40200-014-0104-3","volume":"13","author":"DR Pokharel","year":"2014","unstructured":"Pokharel DR, Khadka D, Sigdel M, Yadav NK, Acharya S, Kafle RC, et al. Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and harmonized criteria. J Diabetes Metab Disord. 2014;13(1):104.","journal-title":"J Diabetes Metab Disord."},{"key":"843_CR10","doi-asserted-by":"publisher","unstructured":"Oliveira CP, de Lima Sanches P, de Abreu-Silva EO, Marcadenti A. Nutrition and physical activity in nonalcoholic fatty liver disease. J Diabetes Res. 2016;2016:4597246. \n                    https:\/\/doi.org\/10.1155\/2016\/4597246\n                    \n                  .","DOI":"10.1155\/2016\/4597246"},{"issue":"1","key":"843_CR11","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1):S47\u201364.","journal-title":"J Hepatol"},{"issue":"3","key":"843_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jhep.2016.05.038","volume":"65","author":"E Bugianesi","year":"2016","unstructured":"Bugianesi E, Rosso C, Cortez-Pinto H. How to diagnose NAFLD in 2016. J Hepatol. 2016;65(3):643. -4-4","journal-title":"J Hepatol"},{"key":"843_CR13","doi-asserted-by":"crossref","unstructured":"Virk A, Steckelberg JM, editors. Clinical aspects of antimicrobial resistance. In: Mayo Clinic Proceedings: Elsevier; 2000.editors","DOI":"10.4065\/75.2.200"},{"issue":"5","key":"843_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/hep4.1055","volume":"1","author":"EM Brunt","year":"2017","unstructured":"Brunt EM. Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation. Hepatology Communications. 2017;1(5):370\u20138.","journal-title":"Hepatology Communications"},{"issue":"4","key":"843_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/17474124.2018.1415756","volume":"12","author":"F Nascimbeni","year":"2018","unstructured":"Nascimbeni F, Ballestri S, Machado MV, Mantovani A, Cortez-Pinto H, Targher G, et al. Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Rev. Gastroenterol. Hepatol. 2018;12(4):351\u201367. (just-accepted)","journal-title":"Expert Rev. Gastroenterol. Hepatol"},{"key":"843_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.metabol.2017.04.003","volume":"72","author":"S Ballestri","year":"2017","unstructured":"Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Targher G, et al. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic\/histological parameters in various liver diseases. Metab Clin Exp. 2017;72:57\u201365.","journal-title":"Metab Clin Exp"},{"issue":"5","key":"843_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","volume":"13","author":"MS Siddiqui","year":"2015","unstructured":"Siddiqui MS, Fuchs M, Idowu MO, Luketic VA, Boyett S, Sargeant C, et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. Clin Gastroenterol Hepatol. 2015;13(5):1000\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"843_CR18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrendo.2017.173","volume":"14","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018;14(2):99\u2013114.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"843_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/ijms17020217","volume":"17","author":"A Mantovani","year":"2016","unstructured":"Mantovani A, Gisondi P, Lonardo A, Targher G. Relationship between non-alcoholic fatty liver disease and psoriasis: a novel Hepato-dermal Axis? Int J Mol Sci. 2016;17(2):217.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"843_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","volume":"59","author":"F Nascimbeni","year":"2013","unstructured":"Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59(4):859\u201371.","journal-title":"J Hepatol"},{"issue":"5","key":"843_CR21","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1053\/gast.2002.36572","volume":"123","author":"AJ Sanyal","year":"2002","unstructured":"Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1705\u201325.","journal-title":"Gastroenterology"},{"key":"843_CR22","volume-title":"Brussels Belgium","author":"Guideline for Type 2 Diabetes","year":"2012","unstructured":"Guideline for Type 2 Diabetes. International diabetes federation. In: Brussels Belgium; 2012."},{"issue":"5\u20136","key":"843_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5\u20136):231\u20137.","journal-title":"Dis Model Mech"},{"issue":"1\u20132","key":"843_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0009-8981(02)00341-8","volume":"327","author":"G Schumann","year":"2003","unstructured":"Schumann G, Klauke R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta. 2003;327(1\u20132):69\u201379.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"843_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/00004836-200609000-00016","volume":"40","author":"C-H Chen","year":"2006","unstructured":"Chen C-H, Huang M-H, Yang J-C, Nien C-K, Yang C-C, Yeh Y-H, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40(8):745\u201352.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"843_CR26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4103\/2230-8210.163172","volume":"19","author":"D Sanyal","year":"2015","unstructured":"Sanyal D, Mukherjee P, Raychaudhuri M, Ghosh S, Mukherjee S, Chowdhury S. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J Endocrinol Metab. 2015;19(5):597.","journal-title":"Indian J Endocrinol Metab"},{"issue":"11","key":"843_CR27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S2221-1691(13)60177-X","volume":"3","author":"DU Mahaling","year":"2013","unstructured":"Mahaling DU, Basavaraj MM, Bika AJ. Comparison of lipid profile in different grades of non-alcoholic fatty liver disease diagnosed on ultrasound. Asian Pac J Trop Biomed. 2013;3(11):907\u201312.","journal-title":"Asian Pac J Trop Biomed"},{"key":"843_CR28","first-page":"351","volume":"59","author":"A Agarwal","year":"2011","unstructured":"Agarwal A, Jain V, Singla S, Baruah B, Arya V, Yadav R, et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India. 2011;59:351\u20134.","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"843_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1758-5996-2-65","volume":"2","author":"A Esteghamati","year":"2010","unstructured":"Esteghamati A, Jamali A, Khalilzadeh O, Noshad S, Khalili M, Zandieh A, et al. Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. Diabetol Meta. Syndr. 2010;2(1):65.","journal-title":"Diabetol Meta. Syndr"},{"key":"843_CR30","unstructured":"Santhoshakumari T, Radhika G, Kanagavalli P. A Study of Anthropometric And Lipid Profile Parameters in Non-Alcoholic Fatty Liver Disease Patients Attending A Tertiary Care Hospital at Puducherry."},{"issue":"2","key":"843_CR31","first-page":"21","volume":"1","author":"R Taslima","year":"2015","unstructured":"Taslima R, Zebunnesa Z, Rahelee Z. Core components of the metabolic syndrome in Nonalcohlic fatty liver disease. J Biochem Biophys. 2015;1(2):21\u20135.","journal-title":"J Biochem Biophys"},{"issue":"5","key":"843_CR32","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3748\/wjg.v9.i5.1106","volume":"9","author":"L Shen","year":"2003","unstructured":"Shen L, Fan J-G, Shao Y, Zeng M-D, Wang J-R, Luo G-H, et al. Prevalence of nonalcoholic fatty liver among administrative officers in shanghai: an epidemiological survey. World J Gastroenterol. 2003;9(5):1106\u201310.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"843_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1751-2980.2011.00487.x","volume":"12","author":"SH Chen","year":"2011","unstructured":"Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011;12(2):125\u201330.","journal-title":"J Dig Dis"},{"key":"843_CR34","doi-asserted-by":"publisher","unstructured":"Sharma SK, Ghimire A, Radhakrishnan J, Thapa L, Shrestha NR, Paudel N, et al. Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens. 2011;2011:821971. \n                    https:\/\/doi.org\/10.4061\/2011\/821971\n                    \n                  .","DOI":"10.4061\/2011\/821971"},{"key":"843_CR35","doi-asserted-by":"publisher","unstructured":"Cordeiro A, Pereira SE, Saboya CJ, Ramalho A. Nonalcoholic fatty liver disease relationship with metabolic syndrome in class III obesity individuals. Biomed Res Int. 2015;2015:839253. \n                    https:\/\/doi.org\/10.1155\/2015\/839253\n                    \n                  .","DOI":"10.1155\/2015\/839253"},{"issue":"3","key":"843_CR36","first-page":"202","volume":"3","author":"G Kirovski","year":"2010","unstructured":"Kirovski G, Schacherer D, Wobser H, Huber H, Niessen C, Beer C, et al. Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. Int J Clin Exp. 2010;3(3):202.","journal-title":"Int J Clin Exp"},{"issue":"2","key":"843_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdiacomp.2008.01.006","volume":"23","author":"R Demirtunc","year":"2009","unstructured":"Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complicat. 2009;23(2):89\u201394.","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"843_CR38","first-page":"1654","volume":"3","author":"B Khadka","year":"2017","unstructured":"Khadka B, Shakya RM, Bista Y. Non-alcoholic fatty liver disease assessment in Nepal. International journal of community medicine and. Public Health. 2017;3(6):1654\u20139.","journal-title":"Public Health"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0843-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-018-0843-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0843-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T19:09:48Z","timestamp":1562353788000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-018-0843-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1186\/s12876-018-0843-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"12 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written permission was taken from Institutional Review Committee (IRC) of Manmohan Memorial Institute of Health Sciences (MMIHS). Letter of approval (Ref No: 116\/MMIHS\/2073) was obtained after submitting and presenting the proposal to the committee. Informed and written consent was taken from the patients before participating in the study. Data regarding personal information were coded and kept confidential.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"109"}}